TYSABRI

Solution for injection in pre-filled syringe, 150mg
RxActive license

Active substance (INN)

natalizumab

Pharmaceutical form

Pharmaceutical formSolution for injection in pre-filled syringe
Strength150mg
PackagingUkupno 2 napunjena injekciona šprica sa 1ml rastvora za injekciju u kartonskoj kutiji
ManufacturerBiogen Netherlands B.V., Netherlands
Therapeutic groupAntineoplastic and immunomodulating agents (L04AG03)
Marketing authorization holderDRUŠTVO ZA TRGOVINU NA VELIKO FARMACEUTSKIM PROIZVODIMA "GLOSARIJ" D.O.O.-PODGORICA
Authorization dateApril 27, 2023

Analogs in Montenegro

1

Other medicines with the same active substance

TYSABRIRx
Concentrate for solution for infusion, 300mg/15mlBiogen Netherlands B.V.
Source: CInMED register